Baxion
ScreeningTagsAlerts

Matinas Biopharma Holdings, Inc.

MTNB·AMEX·$0.73Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/2610-QQ1 ended 03/31/2605/08/2610-KFY 202503/31/2610-QQ3 ended 09/30/2511/10/2510-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report09/28/268-KCurrent report09/16/268-KCurrent report09/04/268-KCurrent report07/24/268-KCurrent report07/13/26

Prospectuses and Registrations

424B7Prospectus06/22/26S-3Shelf registration06/16/26S-8Registration of securities for employees06/23/25424B3Prospectus04/29/25S-3Shelf registration04/22/25

Proxies

DEF 14ADefinitive proxy05/12/25PRE 14APreliminary proxy05/02/25DEF 14ADefinitive proxy03/03/25PRE 14APreliminary proxy02/21/25DEF 14ADefinitive proxy09/19/23

Ownership

Form 4Insider transaction08/13/26Form 4Insider transaction08/13/26SC 13D/ABeneficial ownership (amended)08/13/26SC 13GBeneficial ownership07/14/26SC 13G/ABeneficial ownership (amended)11/14/25

Other

42542508/25/2642542508/04/2642542507/30/2642542507/29/2642542507/21/26

Latest Filings

8-KCurrent report09/28/268-KCurrent report09/16/268-KCurrent report09/04/2642542508/25/2610-QQ2 ended 06/30/2608/13/26

Ownership

Form 4Insider transaction08/13/26Form 4Insider transaction08/13/26SC 13D/ABeneficial ownership (amended)08/13/26SC 13GBeneficial ownership07/14/26SC 13G/ABeneficial ownership (amended)11/14/25
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact